Your Updated Blueprint for Tackling the Toughest Enforcement and Compliance Risks: Cartels and TCOs, Geopolitics, China, AI, Fraud, False Claims and More at the Forefront!
Stay ahead of the curve with key updates from U.S. and international authorities, actionable compliance strategies and the newest risk management best practices at ACI’s FCPA and Anti-Corruption Conference for the Life Sciences Industry.
Connect with legal and compliance leaders in Life Sciences to discuss the very high stakes issues at the top of your mind, including:

• Unpacking New Life Sciences Enforcement Realities
  • New Cartel, TCO, Fraud, False Claims and More High Stakes Risks Under the Microscope
• Mitigating Supply Chain, Distribution and Logistics Risks in the Wake of DOJ’s Cartel and TCO Focus
  • Rethinking Due Diligence, Monitoring and Operations on the Ground
• The Complex Landscape of Market Access and Operations in China
  • Rethinking Compliance Amid the Intensifying Tariff, Trade and Geopolitical Considerations
• The New, Specific False Claims Act Liability Risks in the Life Sciences Context
  • Revisiting Risk Management and Compliance to Address Potential Exposure
• The New Strategies for Utilizing AI to Strengthen Compliance, Monitoring and Risk Management
  • From HCP Engagements, Third Party Monitoring to Patient Safety and Privacy

This is the must‑attend compliance event of the year for life sciences professionals. Don’t miss out on the strategies that will define tomorrow’s compliance landscape.